December 19, 2007 - Toshiba Medical Systems Europe recently announced the companyâs newest product, the Artida ultrasound system, designed to meet the demands of the growing cardiac 4D market.
With Artidaâs real-time multi-planar reformatting capabilities, physicians can reportedly quantify global and regional LV function, including LV ejection fraction, volume and severity of regurgitation. Arbitrary views of the heart not available in 2D imaging are also obtained that can help with surgical planning, according to the company.